SCL Science, a leading total healthcare company, showcased its next-generation bio-logistics platform at the 4th Korea Cold Chain 2026 exhibition, a global cold chain specialty event. The expo took place from March 31 to April 3 at the Korea International Exhibition Center (KINTEX) in Ilsan, Goyang City, Gyeonggi Province.
As the biopharmaceutical, vaccine, and rare drug markets continue to expand, advanced cold chain logistics have become a critical competitive advantage. SCL Science, through its Bio Logistics Division, has developed a cutting-edge operational model featuring specialized cold chain logistics services and a digital logistics management system tailored for the biotech and healthcare sectors.
At the exhibition, SCL Science introduced BIONECT, its proprietary digital logistics platform, which garnered praise from industry experts. BIONECT offers a comprehensive digital logistics process, streamlining everything from order processing to transportation management, data logging, and financial settlement.
Visitors to the company’s booth were given the opportunity to test the system hands-on, generating significant interest. A company spokesperson emphasized that their bio-logistics platform plays a vital role in safeguarding patient safety and ensuring continuity of care. They added that SCL Science aims to make significant strides through digital innovation and by bolstering their specialized capabilities.
